Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Hypertension

Free Subscription 04.12.2023 1 Am J Cardiol 1 Am J Kidney Dis 1 Am J Med 2 Circulation 1 Clin Exp Hypertens 2 Curr Opin Nephrol Hypertens 1 Diabetes Care 1 Eur J Pharmacol 2 Hypertension 1 J Hum Hypertens 10 J Hypertens 1 J Vasc Surg 1 JAMA 7 PLoS One 2 Stroke

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. RUBENS M, Ramamoorthy V, Saxena A, Jimenez J, et al
   Hospital Outcomes Among Pulmonary Hypertension Patients with Atrial Fibrillation in the United States.
   Am J Cardiol. 2023 Nov 29:S0002-9149(23)01347.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

2. SRIALLURI N, Surapaneni A, Chang A, Mackeen AD, et al
   Preeclampsia and Long-term Kidney Outcomes: An Observational Cohort Study.
   Am J Kidney Dis. 2023;82:698-705.
   PubMed         Abstract available
   
   

   
   Am J Med

3. SHI SM, Gouskova N, Park CM, Travison TG, et al
   Balancing Benefit and Harm of Intensive Blood Pressure Lowering Based on Individual Outcome Profile Analysis.
   Am J Med. 2023;136:1196-1202.
   PubMed         Abstract available
   
   

   
   Circulation

4. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
   Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
   Circulation. 2023;148:1825-1826.
   PubMed        
   
   
5. LI G, Chen H, Ren C
   Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
   Circulation. 2023;148:1823-1824.
   PubMed        
   
   

   
   Clin Exp Hypertens

6. YANG J, Jiang G, Huang L, Liu Z, et al
   The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145-5p/HK2 in hypertension.
   Clin Exp Hypertens. 2023;45:2284658.
   PubMed         Abstract available
   
   

   
   Curr Opin Nephrol Hypertens

7. TANTISATTAMO E, Ferrey AJ, Reddy UG, Malik FT, et al
   A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients.
   Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000951.
   PubMed         Abstract available
   
   
8. ALVAREZ-ELIAS AC, Brenner BM, Luyckx VA
   Climate change and its influence in nephron mass.
   Curr Opin Nephrol Hypertens. 2024;33:102-109.
   PubMed         Abstract available
   
   

   
   Diabetes Care

9. KOYAMA AK, Bullard KM, Onufrak S, Xu F, et al
   Risk Factors Amenable to Primary Prevention of Type 2 Diabetes Among Disaggregated Racial and Ethnic Subgroups in the U.S.
   Diabetes Care. 2023;46:2112-2119.
   PubMed         Abstract available
   
   

   
   Eur J Pharmacol

10. VAN DORST DCH, Mirabito Colafella KM, van Veghel R, Garrelds IM, et al
    Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment.
    Eur J Pharmacol. 2023 Nov 27:176199. doi: 10.1016/j.ejphar.2023.176199.
    PubMed         Abstract available
    
    

    
    Hypertension

11. RAY A, Stelloh C, Liu Y, Meyer A, et al
    Histone Modifications and Their Contributions to Hypertension.
    Hypertension. 2023 Nov 30. doi: 10.1161/HYPERTENSIONAHA.123.21755.
    PubMed         Abstract available
    
    
12. JIA G, Sowers JR, Whaley-Connell A
    Obesity in Hypertension: The Role of the Expanding Waistline Over the Years and Insights Into the Future.
    Hypertension. 2023 Nov 29. doi: 10.1161/HYPERTENSIONAHA.123.21719.
    PubMed        
    
    

    
    J Hum Hypertens

13. MANSOORI A, Seifi N, Vahabzadeh R, Hajiabadi F, et al
    The relationship between anthropometric indices and the presence of hypertension in an Iranian population sample using data mining algorithms.
    J Hum Hypertens. 2023 Dec 1. doi: 10.1038/s41371-023-00877.
    PubMed         Abstract available
    
    

    
    J Hypertens

14. RABBITT L, Curneen J, Hobbins A, Browne D, et al
    A cost-analysis of managing secondary and apparent treatment-resistant hypertension in a specialist multidisciplinary hypertension clinic.
    J Hypertens. 2024;42:58-69.
    PubMed         Abstract available
    
    
15. XIONG Y, He Y, Chen Z, Wu T, et al
    Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
    J Hypertens. 2023 Nov 17. doi: 10.1097/HJH.0000000000003613.
    PubMed         Abstract available
    
    
16. NAKAGAWA K, Chen R, Ross GW, Donlon TA, et al
    FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk.
    J Hypertens. 2023 Nov 23. doi: 10.1097/HJH.0000000000003620.
    PubMed         Abstract available
    
    
17. OSCULLO G, Gomez-Olivas JD, Martinez-Garcia MA
    Nocturnal hypertension phenotypes and obstructive sleep apnoea.
    J Hypertens. 2024;42:50-52.
    PubMed        
    
    
18. ARMANINI D, Sabbadin C, Manso J, Boscaro M, et al
    Consideration in the evaluation of follow-up of resistant hypertension.
    J Hypertens. 2024;42:56-57.
    PubMed        
    
    
19. PAIVA AMG, Gomes MICM, Silva EAA, Feitosa ADM, et al
    Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension?
    J Hypertens. 2024;42:186-188.
    PubMed        
    
    
20. KREUTZ R, Palatini P, Stergiou G, Mancia G, et al
    Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
    J Hypertens. 2024;42:188-189.
    PubMed        
    
    
21. FERNANDEZ JR, Mojon A, Smolensky MH, Hermida RC, et al
    Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings.
    J Hypertens. 2024;42:190-191.
    PubMed        
    
    
22. ABDELAZEEM B, Saleh O, Mahmoud A, Abuelazm M, et al
    Authors' response to "Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings".
    J Hypertens. 2024;42:191-192.
    PubMed        
    
    
23. 
    2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Asso
    J Hypertens. 2024;42:194.
    PubMed        
    
    

    
    J Vasc Surg

24. LI SR, Phillips AR, Reitz K, Mikati N, et al
    Hypertension During Transfer is Associated with Poor Outcomes in Unstable Patients with Ruptured Abdominal Aortic Aneurysm.
    J Vasc Surg. 2023 Nov 29:S0741-5214(23)02303-0. doi: 10.1016/j.jvs.2023.
    PubMed         Abstract available
    
    

    
    JAMA

25. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    PubMed         Abstract available
    
    

    
    PLoS One

26. BOACHIE-ANSAH P, Anto BP, Marfo AFA, Dassah ET, et al
    Quality of antenatal care and outcomes of Hypertensive Disorders in Pregnancy among antenatal attendees: A comparison of urban and periurban health facilities in Ghana.
    PLoS One. 2023;18:e0294327.
    PubMed         Abstract available
    
    
27. TRIVEDI P, Chaturvedi V
    Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
    PLoS One. 2023;18:e0292397.
    PubMed         Abstract available
    
    
28. SALAZAR FLOREZ JE, Echeverri Rendon AP, Giraldo Cardona LS
    Burden of undiagnosed hypertension and its associated factors: A challenge for primary health care in urban Colombia.
    PLoS One. 2023;18:e0294177.
    PubMed         Abstract available
    
    
29. CHOI GW, Chang SJ, Kim HJ, Jeong HN, et al
    Understanding health literacy of deaf persons with hypertension in South Korea: A cross-sectional study.
    PLoS One. 2023;18:e0294765.
    PubMed         Abstract available
    
    
30. SINGLETON CMH, Brar S, Robertson N, DiTommaso L, et al
    Cardiometabolic risk factors in South American children: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293865.
    PubMed         Abstract available
    
    
31. TATEAI Y, Kawakami K, Teramae M, Fukuda N, et al
    Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.
    PLoS One. 2023;18:e0294320.
    PubMed         Abstract available
    
    
32. CASTEL-FECED S, Malo S, Aguilar-Palacio I, Feja-Solana C, et al
    Influence of cardiovascular risk factors and treatment exposure on cardiovascular event incidence: Assessment using machine learning algorithms.
    PLoS One. 2023;18:e0293759.
    PubMed         Abstract available
    
    

    
    Stroke

33. ROBERTS R, Huckstepp RTR
    Innate Sleep Apnea in Spontaneously Hypertensive Rats Is Associated With Microvascular Rarefaction and Neuronal Loss in the preBotzinger Complex.
    Stroke. 2023;54:3141-3152.
    PubMed         Abstract available
    
    
34. INCONTRI D, Marchina S, Andreev A, Wilson M, et al
    Etiology of Primary Cerebellar Intracerebral Hemorrhage Based on Topographic Localization.
    Stroke. 2023 Oct 16. doi: 10.1161/STROKEAHA.123.044271.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.